The Modified Glasgow Prognostic Score Predicts Survival in Gastric Cancer Patients with Normal CEA and CA19-9

Background. Traditionally, serum CEA and CA19-9 levels are good prognostic factors for gastric cancer. Many gastric cancer patients do not have elevated CEA or CA19-9 levels even at a very advanced stage. This study investigates the significance of the modified Glasgow prognostic score (mGPS) for th...

Full description

Saved in:
Bibliographic Details
Main Authors: Shun Zhang, Jing-Ze Li, Tao Du, Hai-Qiang Li, Ren-Hao Hu, Chi-Ye Ma, Xi-Mao Cui, Chun Song, Xiao-Hua Jiang
Format: Article
Language:English
Published: Wiley 2022-01-01
Series:Canadian Journal of Gastroenterology and Hepatology
Online Access:http://dx.doi.org/10.1155/2022/3953004
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849693174241427456
author Shun Zhang
Jing-Ze Li
Tao Du
Hai-Qiang Li
Ren-Hao Hu
Chi-Ye Ma
Xi-Mao Cui
Chun Song
Xiao-Hua Jiang
author_facet Shun Zhang
Jing-Ze Li
Tao Du
Hai-Qiang Li
Ren-Hao Hu
Chi-Ye Ma
Xi-Mao Cui
Chun Song
Xiao-Hua Jiang
author_sort Shun Zhang
collection DOAJ
description Background. Traditionally, serum CEA and CA19-9 levels are good prognostic factors for gastric cancer. Many gastric cancer patients do not have elevated CEA or CA19-9 levels even at a very advanced stage. This study investigates the significance of the modified Glasgow prognostic score (mGPS) for the survival of gastric cancer patients with normal CEA and CA19-9. Methods. We retrospectively examined 488 curatively resected gastric cancer patients with normal preoperative serum levels of CEA and CA19-9 to evaluate the prognostic ability of mGPS for overall survival. The prognostic significance was analyzed by univariate and multivariate analyses. Results. Age, hemoglobin, white cell count, and neutrophils were each significantly correlated with the mGPS. Multivariate analyses showed that tumor location (HR, 0.803; 95% CI, 0.667–0.966; P=0.020), TNM stage (HR, 2.714; 95% CI, 2.250–3.275; P<0.001), and mGPS (HR, 1.042; 95% CI, 1.105–1.772; P=0.023) were significantly associated with overall survival. Significant correlations were found between overall survival and mGPS. The Kaplan–Meier analysis demonstrated significant differences among patients with mGPS of 0, 1, and 2 P<0.001, with the mortality rate being higher for patients with a higher mGPS. Conclusion. The mGPS can predict survival in gastric cancer patients with normal CEA and CA19-9.
format Article
id doaj-art-907bf2a7eeb540c0bdcdb3acb0bc8b2a
institution DOAJ
issn 2291-2797
language English
publishDate 2022-01-01
publisher Wiley
record_format Article
series Canadian Journal of Gastroenterology and Hepatology
spelling doaj-art-907bf2a7eeb540c0bdcdb3acb0bc8b2a2025-08-20T03:20:30ZengWileyCanadian Journal of Gastroenterology and Hepatology2291-27972022-01-01202210.1155/2022/3953004The Modified Glasgow Prognostic Score Predicts Survival in Gastric Cancer Patients with Normal CEA and CA19-9Shun Zhang0Jing-Ze Li1Tao Du2Hai-Qiang Li3Ren-Hao Hu4Chi-Ye Ma5Xi-Mao Cui6Chun Song7Xiao-Hua Jiang8Department of Gastrointestinal SurgeryCenter of Digestive EndoscopyDepartment of Gastrointestinal SurgeryDepartment of Gastrointestinal SurgeryDepartment of Gastrointestinal SurgeryDepartment of Gastrointestinal SurgeryDepartment of Gastrointestinal SurgeryDepartment of Gastrointestinal SurgeryDepartment of Gastrointestinal SurgeryBackground. Traditionally, serum CEA and CA19-9 levels are good prognostic factors for gastric cancer. Many gastric cancer patients do not have elevated CEA or CA19-9 levels even at a very advanced stage. This study investigates the significance of the modified Glasgow prognostic score (mGPS) for the survival of gastric cancer patients with normal CEA and CA19-9. Methods. We retrospectively examined 488 curatively resected gastric cancer patients with normal preoperative serum levels of CEA and CA19-9 to evaluate the prognostic ability of mGPS for overall survival. The prognostic significance was analyzed by univariate and multivariate analyses. Results. Age, hemoglobin, white cell count, and neutrophils were each significantly correlated with the mGPS. Multivariate analyses showed that tumor location (HR, 0.803; 95% CI, 0.667–0.966; P=0.020), TNM stage (HR, 2.714; 95% CI, 2.250–3.275; P<0.001), and mGPS (HR, 1.042; 95% CI, 1.105–1.772; P=0.023) were significantly associated with overall survival. Significant correlations were found between overall survival and mGPS. The Kaplan–Meier analysis demonstrated significant differences among patients with mGPS of 0, 1, and 2 P<0.001, with the mortality rate being higher for patients with a higher mGPS. Conclusion. The mGPS can predict survival in gastric cancer patients with normal CEA and CA19-9.http://dx.doi.org/10.1155/2022/3953004
spellingShingle Shun Zhang
Jing-Ze Li
Tao Du
Hai-Qiang Li
Ren-Hao Hu
Chi-Ye Ma
Xi-Mao Cui
Chun Song
Xiao-Hua Jiang
The Modified Glasgow Prognostic Score Predicts Survival in Gastric Cancer Patients with Normal CEA and CA19-9
Canadian Journal of Gastroenterology and Hepatology
title The Modified Glasgow Prognostic Score Predicts Survival in Gastric Cancer Patients with Normal CEA and CA19-9
title_full The Modified Glasgow Prognostic Score Predicts Survival in Gastric Cancer Patients with Normal CEA and CA19-9
title_fullStr The Modified Glasgow Prognostic Score Predicts Survival in Gastric Cancer Patients with Normal CEA and CA19-9
title_full_unstemmed The Modified Glasgow Prognostic Score Predicts Survival in Gastric Cancer Patients with Normal CEA and CA19-9
title_short The Modified Glasgow Prognostic Score Predicts Survival in Gastric Cancer Patients with Normal CEA and CA19-9
title_sort modified glasgow prognostic score predicts survival in gastric cancer patients with normal cea and ca19 9
url http://dx.doi.org/10.1155/2022/3953004
work_keys_str_mv AT shunzhang themodifiedglasgowprognosticscorepredictssurvivalingastriccancerpatientswithnormalceaandca199
AT jingzeli themodifiedglasgowprognosticscorepredictssurvivalingastriccancerpatientswithnormalceaandca199
AT taodu themodifiedglasgowprognosticscorepredictssurvivalingastriccancerpatientswithnormalceaandca199
AT haiqiangli themodifiedglasgowprognosticscorepredictssurvivalingastriccancerpatientswithnormalceaandca199
AT renhaohu themodifiedglasgowprognosticscorepredictssurvivalingastriccancerpatientswithnormalceaandca199
AT chiyema themodifiedglasgowprognosticscorepredictssurvivalingastriccancerpatientswithnormalceaandca199
AT ximaocui themodifiedglasgowprognosticscorepredictssurvivalingastriccancerpatientswithnormalceaandca199
AT chunsong themodifiedglasgowprognosticscorepredictssurvivalingastriccancerpatientswithnormalceaandca199
AT xiaohuajiang themodifiedglasgowprognosticscorepredictssurvivalingastriccancerpatientswithnormalceaandca199
AT shunzhang modifiedglasgowprognosticscorepredictssurvivalingastriccancerpatientswithnormalceaandca199
AT jingzeli modifiedglasgowprognosticscorepredictssurvivalingastriccancerpatientswithnormalceaandca199
AT taodu modifiedglasgowprognosticscorepredictssurvivalingastriccancerpatientswithnormalceaandca199
AT haiqiangli modifiedglasgowprognosticscorepredictssurvivalingastriccancerpatientswithnormalceaandca199
AT renhaohu modifiedglasgowprognosticscorepredictssurvivalingastriccancerpatientswithnormalceaandca199
AT chiyema modifiedglasgowprognosticscorepredictssurvivalingastriccancerpatientswithnormalceaandca199
AT ximaocui modifiedglasgowprognosticscorepredictssurvivalingastriccancerpatientswithnormalceaandca199
AT chunsong modifiedglasgowprognosticscorepredictssurvivalingastriccancerpatientswithnormalceaandca199
AT xiaohuajiang modifiedglasgowprognosticscorepredictssurvivalingastriccancerpatientswithnormalceaandca199